Drug firms’ secret data supercharge AI protein models
Nature
Read the full article
A consortium of pharmaceutical companies enhanced AI protein-folding models by training OpenFold3 on over 20,000 proprietary protein structures, improving performance beyond models trained on public data alone. This highlights the value of private drug company data to advance protein structure prediction and drug discovery.
